scholarly article | Q13442814 |
P2093 | author name string | S Shin | |
M H Park | |||
H Park | |||
E Y Song | |||
K U Park | |||
J W In | |||
E Y Rho | |||
P2860 | cites work | Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients | Q82213207 |
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications | Q34315026 | ||
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. | Q36248631 | ||
Kidney in hypertension: guyton redux | Q37106906 | ||
Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation | Q37306433 | ||
Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients. | Q46727061 | ||
Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis | Q48577521 | ||
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. | Q50674616 | ||
Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. | Q52668051 | ||
Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation | Q56898402 | ||
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension | Q71662795 | ||
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells | Q74317809 | ||
Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts | Q74550738 | ||
The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection | Q79882539 | ||
Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction | Q80379527 | ||
Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies | Q81448662 | ||
Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation | Q81680338 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 3371-3374 | |
P577 | publication date | 2014-12-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | Anti-angiotensin type 1 receptor antibodies associated with antibody-mediated rejection in patients without preformed HLA-donor-specific antibody. | |
P478 | volume | 46 |
Q46409439 | Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation |
Q100408260 | Angiotensin II type 1 receptor antibodies in kidney transplantation: An evidence-based comprehensive review |
Q47571875 | C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies |
Q64939685 | Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies. |
Q37642331 | Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. |
Q48160896 | Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study. |
Q39217968 | Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection |
Q89029587 | Prevalence of Antibody against Angiotensin II Type 1 Receptor (AT1R) Among Thai Kidney Transplant Patients |
Q42233729 | The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes. |
Q53186858 | The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation. |
Q38877375 | The importance of non-HLA antibodies in transplantation |